Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Shivanand Pudakalakatti Image

      Shivanand Pudakalakatti, Ph.D.

      Department of Cancer Systems Imaging, Division of Diagnostic Imaging

      Present Title & Affiliation

      Primary Appointment

      Instructor, Cancer Systems Imaging, Diagnostic Imaging, UT MD Anderson, Houston, Texas

      Education & Training

      Degree-Granting Education

      2015Indian Institute of Science, Bangalore, IN, Chemistry, PhD
      2009Karnatak University, Dharwad, IN, Chemistry, MS
      2007Karnatak Science College, Dharwad, US, Chemistry, Physics, and Mathematics, BS

      Postgraduate Training

      2016-2021Research Fellowship, UT MD Anderson

      Experience & Service

      Other Professional Positions

      Research Investigator, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023

      Postdoctoral Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2021

      Extramural Institutional Committee Activities

      Member, Metabolism in Cancer Symposium Committee, UT MD Anderson, 2024

      Vice-Chair, Annual Postdoctoral Career Symposium (APCS), UT MD Anderson, 2019

      Vice-Chair, Annual Postdoctoral Career Symposium (APCS), UT MD Anderson, 2018

      Member, Postdoctoral Association Executive Committee (PDAEC), UT MD Anderson, 2017

      Editorial Activities

      Guest Editor, Metabolites special issue (Impact Factor 5.581) - Insights into Metabolism, Diagnostics and Therapeutics of Cancer and Tumor Microenvironment by NMR Spectroscopy, 2023 - Present

      Guest Editor, Metabolites special issue (Impact Factor 5.581) - Interrogation of Tumor Metabolism Employing Magnetic Resonance Spectroscopy and Imaging, 2022 - Present

      Honors & Awards

      2019Postdoctoral Travel Award, UT MD Anderson
      2018AACR Scholar-in-Training Awards, AACR
      2018Summa Cum Laude (Gold) Merit Award, 26th Joint Annual Meeting ISMRM-ESMRMB
      2017Trainee travel award, at Division of Diagnostic Imaging Annual Trainee Symposium at MD Anderson Cancer Center
      2014Ernst-Wuthrich Travel Award, Bruker Biospin
      2009Second Prize, the Department of Science and Technology, Government of Karnataka
      2007First Prize, Kittel Science College Dharwad
      1999 - 2004National Merit scholarship (Rural Students), Government of India

      Professional Memberships

      European molecular imaging society

      2024 - Present

      Sigma Xi

      2019 - Present

      World Molecular Imaging Society

      2019 - 2020

      International Society for Magnetic Resonance in Medicine

      2017 - Present

      American Association for the Advancement of Science

      2016 - 2018

      Nuclear Magnetic Resonance Society

      2014 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2018. Identifying immunotherapy resistance in vitro and in vivo by magnetic resonance (. Conference. GCC NMR and Cell Tracking Symposium, Rice University. Houston, TX, US.
      2. 2017. Identifying immunotherapy resistance in melanoma in vitro and in vivo by Magnetic Resonance. Conference. Division of Diagnostic Imaging, University of Texas. Houston, TX, US.
      3. 2017. Early detection of pancreatic cancer by targeted molecular MRI Imaging of hyperpolarized silicon nanoparticles. Conference. Keck Annual Symposium. Houston, TX, US.

      Regional Presentations

      1. 2017. Molecular targeting of MUC1 in colorectal cancer using hyperpolarized magnetic resonance imaging of silicon particles. Conference. Cancer Prevention and Research Institute of Texas Conference. Austin, TX, US.

      National Presentations

      1. 2018. Imaging immunotherapy resistance in melanoma in vitro and in vivo employing magnetic resonance. Conference. Third AACR-SNMMI Joint Conference State-of-Art Molecular imaging in Cancer Biology and Therapy. San Diego, CA, US.

      International Presentations

      1. 2024. Enhancing Immunotherapy Sensitivity in Resistant Melanoma and Early Prediction of Treatment Efficacy Using Hyperpolarized and acidoCEST MRI. Conference. World Molecular Imaging Conference. Montreal, CA.
      2. 2024. Sensitizing immunotherapy resistant melanoma into responsive and interrogating the transformation by hyperpolarized and acidoCEST MR. Conference. European Molecular Imaging Conference. Porto, PT.
      3. 2022. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Conference. 63rd Experimental Nuclear Magnetic Resonance Conference. Orlando, US.
      4. 2021. Application of hyperpolarized magnetic resonance (MR) to therapeutic intervention of melanoma and targeted molecular imaging of colorectal cancer. Invited. Department of studies in Chemistry, Karnataka University. Dharwad, IN.
      5. 2019. Identifying immunotherapy resistance in melanoma in vivo and in vitro employing magnetic resonance imaging and spectroscopy. Conference. World Molecular Imaging Congress. Montreal, CA.
      6. 2018. NMR spectroscopy-based blood test to diagnose brain cancer at early stages. Invited. International Society for Magnetic Resonance in Medicine (ISMRM). Paris, FR.
      7. 2017. Unique molecular signatures to distinguish immunotherapy responding and resistant cell lines in melanoma by NMR spectroscopy and MR hyperpolarization. Conference. Asia-Pacific NMRS. Bangalore, IN.
      8. 2017. Unique Molecular Signatures to Distinguish Immunotherapy Responding and Resistant Melanoma by Magnetic Resonance. Invited. Hyperpolarized study section, International Society for Magnetic Resonance in Medicine (ISMRM). Honolulu, US.
      9. 2014. Accelerating 3D HSQC-DOSY with projection NMR spectroscopy and non-uniform sampling (. Conference. NMRS India Conference, Tezpur University. Assam, IN.
      10. 2014. New fast NMR Methods for accelerating data acquisition and analysis in Metabolomics. Conference. 55th Experimental Nuclear Magnetic Resonance. Boston, US.
      11. 2012. NMR and Metabolomics: Application to Human In Vitro Fertilization. Conference. 18th NMRS India conference. Bangalore, IN.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Whiting N, Hu J, Pudakalakatti S, McCowan CV, Ramezani S, Davis JS, Millward NZ, Engel BJ, Liu JX, Gellci K, Seo H, Brown D, Enriquez JS, Menter DG, Millward SW, Gammon ST, Piwnica-Worms D, Farach-Carson MC, Carson D, Constantinou PE, Bhattacharya P. Targeted Molecular MRI of Colorectal Cancer by Antibody Functionalized Hyperpolarized Silicon Particles. bioRxiv, 2025. e-Pub 2025. PMID: 40654854.
      2. Chin, RL, Li, T, De La Cerda, J, Schuler, WF, Pudakalakatti S, Bhattacharya, PK, Sinharay, S, Pagel, MD. Potentiation of immune checkpoint blockade by esomeprazole as monitored with acidoCEST MRI. British Journal of cancer 138(8):744-753, 2025. e-Pub 2025. PMID: 39994445.
      3. McCowan CV, Salmon D, Hu J, Pudakalakatti S, Whiting N, Davis JS, Carson DD, Zacharias NM, Bhattacharya PK, Farach-Carson MC. Post-Acquisition Hyperpolarized 29Silicon Magnetic Resonance Image Processing for Visualization of Colorectal Lesions Using a User-Friendly Graphical Interface. Diagnostics (Basel) 12(3), 2022. e-Pub 2022. PMID: 35328163.
      4. Tripathi S, Park JH, Pudakalakatti S, Bhattacharya PK, Kaipparettu BA, Levine H. A mechanistic modeling framework reveals the key principles underlying tumor metabolism. PLoS Comput Biol 18(2):e1009841, 2022. e-Pub 2022. PMID: 35148308.
      5. Pudakalakatti S, Titus M, Enriquez JS, Ramachandran S, Zacharias NM, Shureiqi I, Liu Y, Yao JC, Zuo X, Bhattacharya PK. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Int J Mol Sci 23(3), 2022. e-Pub 2022. PMID: 35163565.
      6. Kim J, Jo D, Yang SH, Joo CG, Whiting N, Pudakalakatti S, Seo H, Son HY, Min SJ, Bhattacharya P, Huh YM, Shim JH, Lee Y. 29Si Isotope-Enriched Silicon Nanoparticles for an Efficient Hyperpolarized Magnetic Resonance Imaging Probe. ACS Appl Mater Interfaces 13(48):56923-56930, 2021. e-Pub 2021. PMID: 34793118.
      7. Pudakalakatti S, Audia A, Mukhopadhyay A, Enriquez JS, Bourgeois D, Tayob N, Zacharias NM, Millward SW, Carson D, Farach-Carson MC, Lang FF, Heimberger AB, Bhat KP, Bhattacharya PK. NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors. Reports (MDPI) 4(4), 2021. e-Pub 2021. PMID: 35937580.
      8. Jaiswal AR, Liu AJ, Pudakalakatti S, Dutta P, Jayaprakash P, Bartkowiak T, Ager CR, Wang ZQ, Reuben A, Cooper ZA, Ivan C, Ju Z, Nwajei F, Wang J, Davies MA, Davis RE, Wargo JA, Bhattacharya PK, Hong DS, Curran MA. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype. Cancer Immunol Res 8(11):1365-1380, 2020. e-Pub 2020. PMID: 32917656.
      9. Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW. Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy. Angew Chem Int Ed Engl 58(13):4179-4183, 2019. e-Pub 2019. PMID: 30680862.
      10. Seo H, Choi I, Whiting N, Hu J, Luu QS, Pudakalakatti S, McCowan C, Kim Y, Zacharias N, Lee S, Bhattacharya P, Lee Y. Hyperpolarized Porous Silicon Nanoparticles: Potential Theragnostic Material for 29 Si Magnetic Resonance Imaging. Chemphyschem 19(17):2143-2147, 2018. e-Pub 2018. PMID: 29779258.
      11. Uppangala S, D'Souza F, Pudakalakatti S, Atreya HS, Raval K, Kalthur G, Adiga SK. Laser assisted zona hatching does not lead to immediate impairment in human embryo quality and metabolism. Syst Biol Reprod Med 62(6):396-403, 2016. e-Pub 2016. PMID: 27598006.
      12. D'Souza F, Pudakalakatti SM, Uppangala S, Honguntikar S, Salian SR, Kalthur G, Pasricha R, Appajigowda D, Atreya HS, Adiga SK. Unraveling the association between genetic integrity and metabolic activity in pre-implantation stage embryos. Sci Rep 6:37291, 2016. e-Pub 2016. PMID: 27853269.
      13. Uppangala S, Pudakalakatti S, D'souza F, Salian SR, Kalthur G, Kumar P, Atreya H, Adiga SK. Influence of sperm DNA damage on human preimplantation embryo metabolism. Reprod Biol 16(3):234-241, 2016. e-Pub 2016. PMID: 27492188.
      14. Venkateshaa N, Pudakalakattib SM, Qurishic Y, Atreyab HS, Srivastava C. MnFe2O4–Fe3O4 core–shell nanoparticles as a potential contrast agent for magnetic resonance imaging. Royal Society of Chemistry, 2015. e-Pub 2015.
      15. PUDAKALAKATTI SM, DUBEY A, ATREYA HS. Simultaneous acquisition of three NMR spectra in a single experiment for rapid resonance assignments in metabolomics. Journal of Chemical Sciences 127:1091-1097, 2015. e-Pub 2015.
      16. Pudakalakatti SM, Chandra K, Thirupathi R, Atreya HS. Rapid characterization of molecular diffusion by NMR spectroscopy. Chemistry 20(48):15719-22, 2014. e-Pub 2014. PMID: 25331210.
      17. Pudakalakatti SM, Dubey A, Jaipuria G, Shubhashree U, Adiga SK, Moskau D, Atreya HS. A fast NMR method for resonance assignments: application to metabolomics. J Biomol NMR 58(3):165-73, 2014. e-Pub 2014. PMID: 24488481.
      18. Pudakalakatti SM, Uppangala S, D'Souza F, Kalthur G, Kumar P, Adiga SK, Atreya HS. NMR studies of preimplantation embryo metabolism in human assisted reproductive techniques: a new biomarker for assessment of embryo implantation potential. NMR Biomed 26(1):20-7, 2013. e-Pub 2013. PMID: 22714820.

      Review Articles

      1. Zickus JR, Enriquez JS, Smith P, Sun BT, Wang M, Morales A, Bhattacharya PK, Pudakalakatti S. NMR-Based Metabolomic Profiling for Brain Cancer Diagnosis and Treatment Guidance. Metabolites 15(9), 2025. e-Pub 2025. PMID: 41002991.
      2. Sharma G, Enriquez JS, Armijo R, Wang M, Bhattacharya P, Pudakalakatti S. Enhancing Cancer Diagnosis with Real-Time Feedback: Tumor Metabolism through Hyperpolarized 1-13C Pyruvate MRSI. Metabolites 13(5), 2023. e-Pub 2023. PMID: 37233647.
      3. Pudakalakatti S, Enriquez JS, McCowan C, Ramezani S, Davis JS, Zacharias NM, Bourgeois D, Constantinou PE, Harrington DA, Carson D, Farach-Carson MC, Bhattacharya PK. Hyperpolarized MRI with silicon micro and nanoparticles: Principles and applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 13(6):e1722, 2021. e-Pub 2021. PMID: 33982426.
      4. Enriquez JS, Chu Y, Pudakalakatti S, Hsieh KL, Salmon D, Dutta P, Millward NZ, Lurie E, Millward S, McAllister F, Maitra A, Sen S, Killary A, Zhang J, Jiang X, Bhattacharya PK, Shams S. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. JMIR Med Inform 9(6):e26601, 2021. e-Pub 2021. PMID: 34137725.
      5. Joseph D, Sukumaran S, Chandra K, Pudakalakatti SM, Dubey A, Singh A, Atreya HS. Rapid nuclear magnetic resonance data acquisition with improved resolution and sensitivity for high-throughput metabolomic analysis. Magn Reson Chem 59(3):300-314, 2021. e-Pub 2021. PMID: 33030750.
      6. Dutta P, Salzillo TC, Pudakalakatti S, Gammon ST, Kaipparettu BA, McAllister F, Wagner S, Frigo DE, Logothetis CJ, Zacharias NM, Bhattacharya PK. Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging. Cells 8(4), 2019. e-Pub 2019. PMID: 30978984.

      Other Articles

      1. Pudakalakatti S, Chin R, Pagel MD, Bhattacharya PK Magnetic Resonance Techniques for Assessing in Vivo pH. Archives of Cancer Research and Medicine 2(1), 2022.

      Abstracts

      1. Smith PL, Enriquez JS, Howell R, Roux OL, Pudakalakatti S, Dutta P, McAllister F, Bhattacharya P. Early detection of pancreatic cancer by hyperpolarized magnetic resonance, 2024. e-Pub 2024.
      2. Murley, Abigail G, Pudakalakatti, Shivanand, Padron, William, Wang, Muxin, Armijo, Ryan, Delacerda, Jorge, Dominic A, Chin, Renee, Schuler, William, Rai, Kunal, Pagel, Marty, Bhattacharya, Pratip. Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI 8:130, 2024. e-Pub 2024.
      3. Garcia, Ashley, Enriquez, Jose, Pudakalakatti, Shivanand, Dutta, Prasanta, McAllister, Florencia, Wang, Muxin, Armijo, Ryan, Bhattacharya, Pratip K, PhD. Distinction Between Pancreatitis and Early-Stage Pancreatic Cancer with HP-MRI, 2023. e-Pub 2023.
      4. Sharma, Shankararama, Cheredath, Aswathi, Pudakalakatti, Shivanand M, Uppangala, Shubhashree, Kalthur, Guruprasad, Kumar, Pratap, Atreya, Hanudatta S, Adiga, Satish K, Pal, Debnath. Supporting Information: Using Metabolomics and Machine Learning to Establish a Model to Predict Embryo Implantation Potential:1-5, 2023. e-Pub 2023.
      5. Enriquez JS, Baran N, Pudakalakatti S, Konopleva M, Bhattacharya AP. Assessment of treatment efficacy in T-cell acute lymphoblastic leukemia models with Hyperpolarized MR and NMR metabolomics, 2022. e-Pub 2022.
      6. Jung, Kwanghwa, Park, Junhyoung, Sirupangi, Tirupataiah, Jia, Dongya, Gandhi, Nishant, Pudakalakatti, Shivanand, Elswood, Jessica, Porter, Weston, Putluri, Nagireddy, Zhang, H-F X, Chen, Xi, Bhattacharya, Pratip K, Creighton, Chad J, Lewis, Michael T, Rosen, Jeffrey M, Wong, Lee-Jun C, Das, Gokul M, Osborne, Kent C, Rimawi, Mothaffar F, Kaipparettu, Abraham B. Abstract P3-06-12: Autophagy-mediated survival mechanism to c-Src inhibitor therapy in triple negative breast cancer 80, 2020. e-Pub 2020.
      7. Jaiswal, Ashvin R, Liu, Arthur J, Pudakalakatti, Shivanand, Dutta, Prasanta, Jayaprakash, Priyamvada, Bartkowiak, Todd, Ager, Casey R, Wang, Zhi-Qiang, Reuben, Alexandre, Cooper, Zachary A, Ivan, Cristina, Ju, Zhenlin, Nwajei, Felix, Wang, Jing, Davies, Michael A, Davis, Eric R, Wargo, Jennifer A, Bhattacharya, Pratip K, Hong, David S, Curran, Michael A. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype, 2020. e-Pub 2020.
      8. Jung, KH, Park, JH, Sirupangi, T, Jia, D, Gandhi, N, Pudakalakatti, S, Elswood, J, Porter, W, Putluri, N, Zhang, XH-F, Chen, X, Bhattacharya, PK, Creighton, CJ, Lewis, MT, Rosen, JM, Wong, L-JC, Das, GM, Osborne, CK, Rimawi, MF, Kaipparettu, BA. Abstract P2-02-14: Metabolic regulation and drug resistance in c-Src activated triple negative breast cancer, 2019. e-Pub 2019.
      9. Jaiswal, Ashvin R, Pudakalakatti, Shivanand, Prasanta, Dutta, Liu, Arthur, Bartkowiak, Todd, Ager, Casey, Davies, Michael A, Davis, Richard E, Wargo, Jennifer, Bhattacharya, Pratip K, Hong, David S, Curran, Michael A. Metabolic adaptations confer immunotherapy resistance in melanoma 78(13):1700-1700, 2018. e-Pub 2018.
      10. Dutta P, Pudakalakatti S, Jaiswal A, Curran M, Bhattacharya P. Distinguishing Immunotherapy Resistant and Sensitive Melanoma Xenografts Using 13C-MRS of Hyperpolarized Pyruvate and 1H-NMR Metabolomics 45(6):E579-E579, 2018. e-Pub 2018.
      11. Whiting N, Hu J, Pudakalakatti S, McCowan C, Seo H, Lee Y, Bhattacharya P. Improved Hyperpolarization of Solid and Mesoporous Nanoscale Silicon Particles Using TEMPO Radicals Allows In Vivo 29Si MRI(26):3575, 2018. e-Pub 2018.
      12. Jaiswal, Ashvin R, Pudakalakatti, Shivanand, Dutta, Prasanta, Liu, Arthur, Bartkowiak, Todd, Ager, Casey, Ivan, Cristina, Davis, Eric R, Davies, Michael A, Wargo, Jennifer, Allison, James P, Bhattacharya, Pratip K, Hong, David, Curran, Michael A. Metabolic adaptations establish immunotherapy resistance in melanoma, 2018. e-Pub 2018.
      13. Whiting N, Hu J, Pudakalakatti S, McCowan C, Carson D, Davis J, Millward N, Menter D, Constantinou P, Bhattacharya AP. In Vivo Molecular Imaging of MUC1-Expressing Colorectal Tumors Using Targeted Hyperpolarized Silicon Particles(26):0105, 2018. e-Pub 2018.
      14. Jung, Hwa K, Park, Hyoung J, Sirupangi, Tirupataiah, Jia, Dongya, Pudakalakatti, Shivanand, Gandhi, Nishant, Elswood, Jessica, Putluri, Vasanta, Creighton, Chad J, Porter, Weston, Lewis, Michael T, Chen, Xi, Putluri, Nagireddy, Bhattacharya, Pratip K, Wong, Lee-Jun C, Das, Gokul M, Kaipparettu, Benny A. Inhibition of mitochondrial reprogramming regulated c-Src in triple-negative breast cancer activates autophagy-mediated survival mechanism, 2018. e-Pub 2018.
      15. Pudakalakatti S, Jaiswal A, Dutta P, Curran M, Bhattacharya AP. Unique molecular signatures to distinguish immunotherapy responding and resistant cell lines in melanoma by NMR spectroscopy and MR hyperpolarization(25):5595, 2017. e-Pub 2017.
      16. Pudakalakatti S, Murley, GA, Padron, W, Delacerda, J, Morales, A, Wang, M, Chin, R, Schuler, W, Enriquez, J, Rai, K, Pagel, MD, Bhattacharya, PK. Targeting metabolism to interrogate immunotherapy resistance in melanoma and predicting therapy efficacy employing HP-MRSI. ISMRM.

      Book Chapters

      1. Pudakalakatti, S, Raj, P, Salzillo, TC, Enriquez, JS, Bourgeois, D, Dutta, P, Titus, M, Shams, S, Bhosale, PR, Kim, M, McAllister, F, Bhattacharya, PK. Metabolic Imaging Using Hyperpolarization for Assessment of Premalignancy, 169-180, 2022.
      2. Pudakalakatti S, Raj P, Salzillo TC, Florencia M, Titus M, Dutta P, et al. Cancer Immunoprevention: Methods and Protocols. In: Methods in Molecular Biology, 2022.
      3. Dubey A, Pudakalakatti S, Atreya HS. Fast NMR Methods for Identification of Resonances and Metabolic Pathways. In: NMR-Based Metabolomics, 135-137, 2019.
      4. Lin C, Salzillo TC, Bader DA, Wilkenfeld SR, Awad D, Pulliam TL, Dutta P, Pudakalakatti S, Titus M, McGuire SE, Bhattacharya PK, Frigo DE. Prostate Cancer Energetics and Biosynthesis. In: Prostate Cancer - Cellular and Genetic Mechanisms of Disease Development and Progression, 2019.
      5. Salzillo TC, Hu J, Nguyen L, Whiting N, Lee J, weygand J, Dutta P, Pudakalakatti S, et al. Interrogating metabolism in brain cancer. In: Magnetic Resonance Imaging Clinics of North America, 2016.
      Read More
      Less

      Patient Reviews


      CV information above last modified October 02, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top